NEW YORK (GenomeWeb News) – DiscoveryBioMed today said that it has inked a service contract with Lifeline Cell Technology to conduct primary human cell bioassay testing for the subsidiary of International Stem Cell Corp.
The contract partners DBM's expertise in assay development with Lifeline's expertise in producing optimized human adult and stem cell products, said Lifeline CEO Jeffrey Janus.
Birmingham, Ala.-based DBM also said that the partners are developing a mutual Small Business Innovation Research grant proposal based on using multiple human cell cultures derived from different tissues as an in vitro platform for testing pollutant, candidate therapeutics and existing drugs for toxicity against cells.
Financial and other terms of the contract were not disclosed.